| 1 | Appropriateness of direct oral anticoagulant dosing in
relation to renal function at hospital discharge | Hiba Ali |
| 2 | Guiding off-label use of direct-acting oral anticoagulants
(DOACs): A multidisciplinary approach | Jessica Bailey |
| 3 | Medication related gastrointestinal bleeding and the
incidence of potential culprit medications: A retrospective study | Maxwell Baker |
| 4 | A plan to beat the pain: The implementation of personalised
post-operative pain management plans | Katina Black |
| 5 | From palliation to recuperation: Phenytoin & pharmacist
to the rescue | Katina Black |
| 6 | Nicotine Replacement Therapy (NRT) charting patterns in a hospital setting | Van Tran |
| 7 | Pyridoxal-5-Phosphate: The route cause | Sophie Brown |
| 8 | Intraocular pressure monitoring variations with topical
corticosteroids prescribing and use
| Ljubica Bukorovic |
| 9 | Granisetron in the treatment of Hyperemesis Gravidarum | Rebecca Butler-Mader |
| 10 | Efficacy of intensive Tacrolimus level monitoring post
Itraconazole cessation in preventing cardiac transplant (CTX) rejection | Lilibeth Carlos |
| 11 | Leucovorin support to minimise mucositis in pralatrexate
therapy | Angela Chen |
| 12 | Cost model assessing flat and weight-based dosing of
nivolumab immunotherapy | Jonathan Chew |
| 13 | A case series of early presentation PE and DVT in renal
transplant recipients | Donald Chu |
| 14 | A patient centred approach to managing minimal change
disease | Brynley Cooper |
| 15 | Carbetocin vs Oxytocin for postpartum haemorrhage
prophylaxis | Evia Corfias |
| 16 | Successful use of Apixaban following Rivaroxaban induced
hepatotoxicity | Mariana De Sousa |
| 17 | Multi-site drug use evaluation: Phosphate replacement point
prevalence audit | Michelle Edmonds |
| 18 | Impact of a local procedure for intrapleural lysis on
prescribing practices | Catherine Edmunds |
| 19 | Mental health medication management – interactions,
metabolism, levels and deprescribing | Denis Finnegan |
| 20 | A retrospective audit of Phenytoin loading and therapeutic
drug monitoring | Rhiannon Froude |
| 21 | Experiences from conducting a survey with a Culturally and
Linguistically Diverse (CALD) patient group | Brent Geihlick |
| 22 | High volume continuous venovenous haemodiafiltration for the treatment of
lactic acidosis following a Metformin
overdose | Ming Gene Chai |
| 23 | Making waves with Heparin – intraprocedural use in pulmonary
vein isolation | Christopher George |
| 24 | Be suspicious, very suspicious! Curious case of drug induced
‘seizures’ | Gauri Godbole |
| 25 | Perinatal outcomes following intravenous compared with oral
Iron for the treatment of antenatal Iron-deficiency anaemia | Dr Luke Grzeskowiak |
| 26 | Buprenorphine post upper gastrointestinal surgeries – a
retrospective cohort study | Galahad Gu |
| 27 | Fenofibrate induced neutropenia during stabilised clozapine
therapy: role of the pharmacist in identifying adverse reactions | Jacky Hanh |
| 28 | Prickly Business: developing skin prick testing for
antineoplastic therapy | Luke Harb |
| 29 | Clozapine-induced hepatotoxicity: A case report | Kim Hoang Le |
| 30 | The use of Aripiprazole long-acting injectable at a major
health service: A longitudinal observational study | Amanda Horiniak |
| 31 | Novel human cancer cell-line models using CRISPR/Cas9 for
assessing Methotrexate genomics: MiSSK Study – Phase-I | Zeyad Ibrahim |
| 32 | Comparing inpatient OxyContin® and Targin® prescribing –
does it affect aperient prescribing or administration? | Laura Kavanagh |
| 33 | Relationship between medication adherence and beliefs around
health and medicines in outpatients with cardiovascular disease
| Brienna Keates |
| 34 | Congenital toxoplasmosis in pregnancy: Preparing for the
neonatal outcome | Tamara Lebedevs |
| 35 | Evaluation of novel oral anticoagulants dosing in patients
with atrial fibrillation in a tertiary hospital | Amaris Lee |
| 36 | Understanding patient perceptions of the delivery of
patient-centred care by clinical pharmacists | Hannah Leeson |
| 37 | Stroke survivors’ poor adherence to secondary preventative
stroke medications – what are their beliefs? | Catherine Li |
| 38 | Dexmedetomidine-associated hyperthermia: A retrospective
cohort study | Daniel Lim |
| 39 | Euglycaemic diabetic ketoacidosis with SGLT2 inhibitors: Is
it more than just a perioperative problem? | Gina Mclachlan |
| 40 | Riding the wave of Clozapine levels and respiratory illness | Renju Mathew |
| 41 | Ratting out the answer: Post-acute patient safety in
Rodenticide overdose | Ariana McCauley |
| 42 | Intrathecal Morphine plus patient-controlled analgesia
versus patient-controlled analgesia alone in colorectal cancer surgery | Alistair Macpherson |
| 43 | Pretty (effective) in pink. Digoxin-specific antibody for
Pink Oleander poisoning. | Tabitha Medara |
| 44 | Infliximab for the management of treatment resistant Central
Nervous System (CNS) Vasculitis: A case report | Anna Mejia |
| 45 | Precision dosing in oncology pharmacy practice: a review of
prospective on-therapy dose adaption strategies | Bradley Menz |
| 46 | The appropriateness of Rivaroxaban drug level monitoring and
the impact on clinical management of patients | Hayley Michael |
| 47 | Do Emergency Department healthcare professionals have
sufficient knowledge of inhaler
technique to educate patients effectively? | Dana Strumpmann |
| 48 | Pharmaceutical opioid related ambulance attendances: an
observational study of Australian trends from 2013-2018. | A/Prof Suzanne Nielsen |
| 49 | Improving physical health in mental health: pharmacists’
impact | Grace O’Halloran |
| 50 | A retrospective review of Clozapine-induced myocarditis and
cardiomyopathy at a metropolitan mental health service | Frances Paterson |
| 51 | Antiresorptive therapy post neck of femur fractures – how
good are we at prescribing? | Samantha Penney |
| 52 | Salvaging from the depths of Serotonin withdrawal syndrome | Edward Perin |
| 53 | The ketone crisis: drug use evaluation of SGLT2 inhibitors
and ketoacidosis | Eve Pinkerton |
| 54 | A resourceful approach to novel treatment of congenital
Myasthenia Gravis | Anish Philip |
| 55 | Pharmacist prevents wipeout for a patient on Perampanel | Tanya Piper |
| 56 | Patient perceptions of opioids for pain management in the
hospital setting: a systematic review | Dr Lisa Pont |
| 57 | Reusable bags – a sustainability initiative for the
transport and delivery of medications | Emily Potter |
| 58 | Battle of substance P: A drug use evaluation of oral
netupitant vs. IV fosaprepitant | Ella Raguz |
| 59 | Are we overdosing older people with Paracetamol in hospital? | Olivia Reid |
| 60 | Implementation of pharmacist-led interventions to improve
staff knowledge and management of agitated delirium | Jessica Rhodes |
| 61 | Less is More: Deprescribing in renal patients on a
conservative management pathway | Michelle Rice |
| 62 | Drug use evaluation of TNF-alpha antagonists for
non-infectious uveitis at a Western Australian tertiary hospital | Matthew Rooney |
| 63 | Review of all Clozapine clinics in a mental health service:
Governance, operations, issues and solutions | Amy Sieff |
| 64 | Management of loculated pleural effusion in a regional
hospital – medications an alternative to surgery? | Vaidehi Solanki |
| 65 | Interacting with interactions – Orkambi® roll-out at a
paediatric hospital | Sonya Stacey |
| 66 | Anticoagulation prescribing and documentation in a tertiary
emergency and trauma centre – the clot thickens. | Belinda Swan |
| 67 | A NSW Review of the use and location of snake antivenom | Amy Thomson |
| 68 | Flecainide’s role in refractory neuropathic pain: A case
report | Natalie Thorp |
| 69 | Multimodal antiemetic prescribing for post-operative
surgical patients | Van Tran |
| 70 | Prophylactic Enoxaparin dosing in obese orthopaedic
patients: A literature search | Van Tran |
| 71 | The impact of a Medicines Information (MI) service on
recognition and management of antiepileptic toxicity | Helen Trenerry |
| 72 | The management of Carbamazepine-induced hyponatraemia and
prevention of Valproate toxicity by Medicines Information (MI) service | Helen Trenerry |
| 73 | Talking with teens: Evaluation of adolescent mental health
education sessions | Maggie Tso |
| 74 | Aspirin for Thromboprophylaxis in Orthopaedic Surgery (ATOS
study) | Nameer van Oosterom |
| 75 | Ask a pharmacist first – a case of preventable interaction
between Chromium and Levothyroxine | Lavinia Verduci |
| 76 | Evaluation of anticoagulation appropriateness post-ischaemic
stroke secondary to atrial fibrillation | Jasmine Walker |
| 77 | Improving medicines governance through a streamlined
Individual Patient Use (IPU) approval process | Jo Wallace |
| 78 | Three cases of significant hypophosphataemia associated with
intravenous Iron | Tania Watene |
| 79 | Survey of Australian hospital pharmacy departments regarding
initiatives in place to care for Aboriginal inpatients | Susie Welch |
| 80 | Dosing intravenous Iron: Keep it simple | Karl Winckel |
| 81 | Paliperidone 3-monthly injection: Experience in a real world
setting | Alice Wisdom |
| 82 | A multidisciplinary smoking cessation support group in
mental health: Combining pharmacy and occupational therapy treatments | Martin Wong |
| 83 | Making fat blood thin: Venous thromboembolism (VTE)
prophylaxis on discharge in the morbidly obese | Martin Wong |
| 84 | Connecting the dots of care: Retrospective review of
Aboriginal admissions – data collection pilot | Carolyn Woods |
| 85 | Extended thromboprophylaxis in high-risk surgery: a review
of current practice | Assmaa Zeno |
| 86 | Systematic literature review: The role of the Australian
hospital pharmacist/pharmacy in providing Aboriginal people services | Susan Welch |
| 87 | The pharmacist’s role in implementing a ketogenic diet in a
patient with super-refractory status epilepticus | Geoffrey Wills |
| 88 | Use of a self-reported measure of medication adherence in a
chronic kidney disease clinic | Carla Scuderi |